DeutschNewstral
Article
Fft.com on 2021-02-18 01:35
BioNTech/Pfizer vaccine is less potent against South African variant
Related news
Pfizer-BioNTech Vaccine Is Effective Against South African Variant, New Research Showswsj.com
Study: Pfizer COVID-19 Vaccine May Be Less Effective Against South African Variantslate.com- HIsraeli Study Shows Pfizer Vaccine Less Effective Against South African Varianthamodia.com
Pfizer vaccine less effective against South African variant, Israeli study findstimesofisrael.com
South African COVID variant can ‘break through’ Pfizer vaccine: studyNew York Post
Study: Pfizer vaccine effective in neutralizing South African variantisraelnationalnews.com
BioNTech/Pfizer protects against hospitalization in South African Omicron wavePolitico.eu- 'Vaccine is less effective against South African variant'israelnationalnews.com
Pfizer/BioNTech, Moderna expect data on shot’s protection against new COVID-19 variant soonamny.com
The Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New “real-World” Study From IsraelForbes
News24.com | Scientists to discuss Pfizer/BioNTech vaccine lab study which found decreased protection vs variantNews24- HPfizer/BioNTech COVID-19 Vaccine Neutralizes Brazil Variant in Lab Studyhamodia.com
- FBioNTech and Pfizer trial data signal protection against South Africa variantft.com
Pfizer-BioNTech pushing 3-dose COVID-19 vaccination to fight omicron variantCBC
Omicron: Pfizer-BioNTech COVID-19 vaccine may only partially protect against new variant, study suggestsFox News- HIsraeli Study: South African Variant May ‘Break Through’ Pfizer Vaccine Protectionhamodia.com
South African variant can ‘break through’ Pfizer vaccine, Israeli study saysThe Japan Times- Pfizer to test booster dose for South African COVID-19 varianttimesofisrael.com
- Pfizer, Moderna COVID-19 vaccines protection against South African variant unclear, studies findFox News
Coronavirus: South African variant can ‘break through’ Pfizer vaccine, Israeli study saysSouth China Morning Post